36.20USD-1.44%Mkt Cap: 991.60M $P/E: —1d ago
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Pricier
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap991.60M $
Enterprise Value1.00B $
Revenue (TTM)86.93M $
Gross Profit42.74M $
Net Income (TTM)-4.60M $
Revenue/Share3.219 USD
Last Price36.20 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees44
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)19.26
PEG—
EV/EBITDA90.50
EV/Revenue11.54
P/S11.41
P/B32.35
EPS (TTM)-0.06
EPS (Forward)1.88
52W Range
13.5195% of range37.49
52W High37.49 USD
52W Low13.51 USD
Profitability
Gross Margin53.46%
Oper. Margin11.39%
EBITDA Margin12.75%
Profit Margin-5.75%
ROE-17.59%
ROA-4.99%
Growth
Revenue Growth40.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.52M $
CapEx (TTM)333.00K $
FCF Margin2.81%
FCF Yield0.25%
Net Debt11.60M $
Net Debt/EBITDA1.05
Balance Sheet
Debt/Equity1.19
Current Ratio1.21
Quick Ratio0.75
Book Value/Sh1.119 USD
Cash/Share0.7180 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.67 USD
Upside (mean)+26.2%
Target Range40.00 USD – 57.00 USD
$40.00+26.2% to mean$57.00
# Analysts3
Ownership
Shares Out.27.39M
Float21.13M
Insiders4.45%
Institutions65.41%
Short Interest
Short Ratio3.5d
Short % Float7.32%
Short % Out.5.20%
Shares Short1.43M
Short (prev mo.)1.55M
Technical
SMA 5029.94 (+20.9%)
SMA 20021.22 (+70.6%)
Beta0.89
S&P 52W Chg20.05%
Avg Vol (30d)361.25K
Avg Vol (10d)474.10K
Technical Indicators
RSI (14)70.1
MACD1.6345
MACD Signal1.2357
MACD Hist.+0.3987
BB Upper37.45 USD
BB Middle32.06 USD
BB Lower26.68 USD
BB Width33.61%
ATR (14)1.663 USD
Vol Ratio (20d)1.25x